← Back to Search

Alkylating agents

Galunisertib for Ovarian Carcinosarcoma

Phase 1
Waitlist Available
Led By Kathleen Moore, MD
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 3 years
Awards & highlights

Study Summary

This trial is testing a new cancer drug to see if it is safe and effective for patients with a type of cancer called carcinosarcoma of the uterus or ovary.

Eligible Conditions
  • Ovarian Carcinosarcoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of patients with completion of 4 cycles of CT + GB
Secondary outcome measures
Incidence and severity of adverse events
Mean (SD) of GB serum concentration levels on day 4, 8 and 29 (cycle 2 day 1)
Median overall survival (months)
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Paclitaxel/Carboplatin + GalunisertibExperimental Treatment3 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Galunisertib
Not yet FDA approved
Carboplatin
FDA approved
Paclitaxel
FDA approved

Find a Location

Who is running the clinical trial?

Eli Lilly and CompanyIndustry Sponsor
2,624 Previous Clinical Trials
3,216,898 Total Patients Enrolled
University of OklahomaLead Sponsor
455 Previous Clinical Trials
95,630 Total Patients Enrolled
1 Trials studying Ovarian Carcinosarcoma
20 Patients Enrolled for Ovarian Carcinosarcoma
Kathleen Moore, MDPrincipal InvestigatorObstetrics and Gynecology
8 Previous Clinical Trials
419 Total Patients Enrolled
~3 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top